Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
64,290 ILa | -2.74% | +2.98% | -11.32% |
06-14 | Morgan Stanley Adjusts Price Target on NICE to $240 From $290, Maintains Overweight Rating | MT |
06-12 | RBC Capital Cuts Price Target on NICE to $230 From $265, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.32% | 10.98B | |
+17.69% | 3,282B | |
+14.62% | 89.87B | |
+14.59% | 84.32B | |
+37.27% | 51.82B | |
-19.27% | 50.56B | |
+32.93% | 46.77B | |
+83.75% | 42.82B | |
-32.70% | 40.61B | |
-1.24% | 27.6B |
- Stock Market
- Equities
- NICE Stock
- News NICE Ltd.
- RBC Raises Price Target on NICE to $265 From $240, Citing 'Clean' Q2 With Margin Expansion, 2022 Guidance Boost; Outperform Kept